trending Market Intelligence /marketintelligence/en/news-insights/trending/9dyY8pqJXwNyiP8SAfzkRg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Tandem Diabetes closes common stock, warrants offering

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Tandem Diabetes closes common stock, warrants offering

Tandem Diabetes Care Inc. closed its public offering of 4,630,000 common shares as well as series A and series B warrants at $3.50 apiece with expected net proceeds of about $14.8 million.

Each common share comes bundled with the two warrants, each to purchase an additional stock in the company for $3.50 apiece.

The net proceeds will be used for working capital and general corporate purposes.

Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering. National Securities Corp. acted as co-manager.